サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1076390

移植市場の規模、シェア、動向分析レポート：製品別（組織製品、免疫抑制剤、保存液）、用途別（臓器、組織移植）、最終用途別、セグメント別予測、2022年～2030年

Transplantation Market Size, Share, & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
移植市場の規模、シェア、動向分析レポート：製品別（組織製品、免疫抑制剤、保存液）、用途別（臓器、組織移植）、最終用途別、セグメント別予測、2022年～2030年
出版日: 2022年04月12日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

移植市場の成長と動向

グランドビューリサーチ社の最新レポートによると、世界の移植市場規模は2030年までに309億米ドルに達し、CAGR9.4％で拡大すると予測されています。

臓器不全の発生率が高まっていることが、移植市場の大幅な成長をもたらしています。

組織製品、免疫抑制剤、臓器保存ソリューションなどの移植製品に対する需要の高まりは、予測期間中の市場成長を後押しする主な要因となっています。そのため、多くのバイオテクノロジー企業や医療機器企業が、臓器不全の管理のための高度な移植製品の開発に力を入れ始めています。

臓器移植法の技術的進歩も、市場の成長を支える主要な要因の一つです。組織製品や手術器具など、新規かつ改良された移植製品の開発は、この分野の拡大に大きく寄与しています。

また、DeNovo NT Graft、Chondrofix Osteochondral Allograft、DuraMatrix Collagen Dura Substitute Membraneなどの高度な組織製品の導入は、治療中に高い利益をもたらします。また、コンピュータを利用したサポートシステムにより、組織のメンテナンスが容易になり、効果的な治療が可能になりました。このように、高度な技術を利用できることが、臓器移植手術の件数の増加を支えているのです。

臓器移植市場のレポートハイライト

  • 組織や臓器の移植手術数の増加により、組織製品分野が最大の売上高を記録
  • 移植製品の進歩により、組織製品分野は最も高いCAGRで成長すると予想される
  • 皮膚、骨、心臓弁、角膜、腱、神経、静脈の手術件数が世界的に増加していることから、組織移植分野が最大の売上シェアを占めている
  • 移植センターは、移植手術の人気上昇により、予測期間中に最も高いCAGRで拡大すると予測される
  • 病院で行われる移植手術の数が多いことから、2021年の売上高では病院セグメントが優位を占める
  • 2021年の地域別売上高では北米がトップであり、医療インフラの充実により予測期間中も優位性を維持すると予測される
  • 北米地域には多数の研究所、バイオテクノロジー、医療機器企業が存在することが大きなシェアを占める主な要因

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 製品タイプ
    • アプリケーションタイプ
    • 最終用途
    • リージョンスコープ
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査内容
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析（モデル1）
      • アプローチ1：コモディティフローアプローチ
    • ボリューム価格分析（モデル2）
      • アプローチ2：出来高分析
  • 二次情報一覧
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
    • 製品タイプの見通し
    • アプリケーションタイプの見通し
    • 最終使用の見通し
    • 地域の見通し
  • 競合考察

第3章 移植市場の変数、動向、範囲

  • 市場系列の見通し
    • 親会社の市場見通し
    • 関連/補助的な市場の見通し
  • 浸透と成長の見通しのマッピング
  • 業界バリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
      • 臓器不全の発生率の増加
      • 移植方法の技術進歩
      • 組織バンクの開発
    • 市場抑制分析
      • 臓器提供者の不足
      • 倫理的および文化的問題
    • 重要な機会を優先
      • 製品ごとに優先される主要な機会
      • アプリケーション別に優先される主要な機会
      • 最終用途別に優先順位付けされた主要な機会
  • 移植市場分析ツール
    • 業界分析- ポーターズ
      • サプライヤーの力
      • 買い手の交渉力
      • 代替の脅威
      • 新規参入者の脅威
      • 競争企業間の敵対関係
    • PESTEL分析
      • 政治情勢
      • 技術情勢
      • 経済情勢
    • 主要な取引と戦略的提携の分析
    • 市場参入戦略

第4章 製品タイプの推定・動向分析別移植市場

  • 定義と範囲
    • ティッシュ製品
    • 免疫抑制剤
    • 保存ソリューション

第5章 移植市場：アプリケーションタイプの推定・動向分析

  • 定義と範囲
    • 臓器移植
    • 組織移植
  • 製品市場シェア、2021年と2030年
  • セグメントダッシュボード
  • アプリケーションの種類別の世界の移植市場の見通し
    • 臓器移植
    • 組織移植

第6章 移植市場：最終用途の推定・動向分析

  • 定義と範囲
    • 病院
    • 移植センター
    • その他
  • 製品市場シェア、2021年と2030年
  • セグメントダッシュボード
  • 世界の移植市場エンドユースエンドユースチャネルの見通し
    • 病院
    • 移植センター
    • その他

第7章 移植市場：国の推定・動向分析

  • 国別市場シェア分析、2021年および2030年
  • 郡市場ダッシュボード
  • 地域市場のスナップショット
  • 2021年の地域市場シェアと主要企業
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 要因別SWOT分析（政治と法律、経済と技術）
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 2021年から2030年までの市場規模、予測、量および傾向分析：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア

第8章 競合情勢

  • Recent Developments &Impact Analysis, By Key Market Participants
  • Company/Competition Categorization
    • イノベーター
  • Vendor Landscape
    • 主要なディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2021年
    • ストライカー株式会社
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • メドトロニック
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • アッヴィ株式会社
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • ジマー・バイオメット
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • ノバルティス
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • 21世紀医学
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • バイオライフソリューション
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • テバ製薬
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
    • ベロクシス・ファーマシューティカルズ
      • 会社概要
      • 財務実績
      • 手順のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America transplantation market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 3 North America transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 4 North America transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 5 North America transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 6 U.S. transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 7 U.S. transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 8 U.S. transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 9 Canada transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 10 Canada transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 11 Canada transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 12 Europe transplantation market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 13 Europe transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 14 Europe transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 15 Europe transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 16 U.K. transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 17 U.K. transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 18 U.K. transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 19 Germany transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 20 Germany transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 21 Germany transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 22 France transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 23 France transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 24 France transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 25 Italy transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 26 Italy transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 27 Italy transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 28 Spain transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 29 Spain transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 30 Spain transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 31 Asia Pacific transplantation market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 32 Asia Pacific transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 33 Asia Pacific transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 34 Asia Pacific transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 35 China transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 36 China transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 37 China transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 38 Japan transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 39 Japan transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 40 Japan transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 41 India transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 42 India transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 43 India transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 44 Latin America transplantation market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 45 Latin America transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 46 Latin America transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 47 Latin America transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 48 Brazil transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 49 Brazil transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 50 Brazil transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 51 Mexico transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 52 Mexico transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 53 Mexico transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 54 MEA transplantation market, by region, 2018 - 2030 (Revenue, USD Million)
  • Table 55 MEA transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 56 MEA transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 57 MEA transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 58 South Africa transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 59 South Africa transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 60 South Africa transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)
  • Table 61 Saudi Arabia transplantation market, by product type, 2018 - 2030 (Revenue, USD Million)
  • Table 62 Saudi Arabia transplantation market, by application, 2018 - 2030 (Revenue, USD Million)
  • Table 63 Saudi Arabia transplantation market, by end use, 2018 - 2030 (Revenue, USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Transplantation market, 2018
  • Fig. 14 Transplantation market segmentation
  • Fig. 15 Transplantation market trends
  • Fig. 16 Transplantation market: market driver impact
  • Fig. 17 Transplantation market: market restraint impact
  • Fig. 18 Penetration & growth prospect mapping
  • Fig. 19 Transplantation market - PESTLE Analysis
  • Fig. 20 Industry Analysis - Porter's
  • Fig. 21 Transplantation market competitive landscape: Market position analysis (Based on products, regional presence)
  • Fig. 22 Transplantation market: Product outlook key takeaways
  • Fig. 23 Transplantation market: Product movement analysis
  • Fig. 24 Tissue products market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Immunosuppressive drugs market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Preservation solution market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 27 Transplantation market: Application movement analysis
  • Fig. 28 Transplantation market: 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Organ transplantation market: 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Tissue transplantation market: 2018 - 2030 (Revenue, USD Million)
  • Fig 31 Transplantation market: End use outlook key takeaways
  • Fig 32 Transplantation market: End use movement analysis
  • Fig. 33 Hospitals market, 2018 - 2030 (Revenue, USD Million)
  • Fig 34 Transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Others market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 36 Regional marketplace, 2018 - 2030 (Revenue, USD Million)
  • Fig. 37 North America transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 U.S. transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Canada transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 Europe transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 41 U.K. transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 42 Germany transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 43 France transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 44 Italy transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 45 Spain transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 46 Asia Pacific transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 47 Japan transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 48 China transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 49 India transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 50 Latin America transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 51 Brazil transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 52 Mexico transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 53 Middle East and Africa i transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 54 South Africa transplantation market, 2018 - 2030 (Revenue, USD Million)
  • Fig. 55 Saudi Arabia transplantation market, 2018 - 2030 (Revenue, USD Million)
目次
Product Code: GVR-1-68038-864-0

Transplantation Market Growth & Trends:

The global transplantation market size is expected to reach USD 30.9 billion by the year 2030, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in massive growth in the transplantation market.

Rising demand for transplant products such as tissue products, immunosuppressants, and organ preservation solutions is a major factor anticipated to boost the market's growth during the forecast period. Thus, many biotechnology and medical device companies have begun to concentrate on the development of advanced transplant products for the management of organ failure.

Technological advancement in organ transplantation methods is another major factor supporting the market growth. The development of novel & improved transplant products such as tissue products and surgical instruments has majorly contributed to the expansion of the sector.

In addition, the introduction of advanced tissue products such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane provides higher benefits during treatment. In addition, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports an increase in the number of organ transplant procedures.

Transplantation Market Report Highlights:

  • Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
  • Tissue products segment is also expected to rise at the highest CAGR owing to advancements in transplantation products
  • Tissue transplant segment held the largest revenue share in the market, because of the rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
  • The transplant centers segment is projected to expand at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
  • The hospitals segment dominated the market in terms of revenue in 2021 owing to a large number of transplant procedures performed in hospitals
  • North America was the leading regional sector in 2021 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
  • Existence of a large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product type
    • 1.1.2. Application type
    • 1.1.3. End use
    • 1.1.4. Region scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Application type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transplantation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing incidence of organ failure
      • 3.4.1.2. Technological advancement in transplantation method
      • 3.4.1.3. Developed tissue banks
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Shortage of organ donors
      • 3.4.2.2. Ethical and cultural issues
    • 3.4.3. Key opportunities prioritized
      • 3.4.3.1. Key opportunities prioritized, by Product
      • 3.4.3.2. Key opportunities prioritized, by application
      • 3.4.3.3. Key opportunities prioritized, by end use
  • 3.5. Transplantation Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies

Chapter 4. Transplantation Market by Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Tissue products
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 4.1.2. Immunosuppressive drugs
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 4.1.3. Preservation Solutions
      • 4.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Transplantation Market: Application Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Organ transplant
    • 5.1.2. Tissue transplant
  • 5.2. Product Market Share, 2021 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Transplantation Market by Application Type Outlook
    • 5.4.1. Organ transplant
      • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Tissue transplant
      • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Transplantation Market: End-Use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Transplantation centers
    • 6.1.3. Others
  • 6.2. Product Market Share, 2021 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Transplantation MarEnd-UseEnd Use Channel Outlook
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Transplantation centers
      • 6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Transplantation Market: Country Estimates & Trend Analysis

  • 7.1. Country Market Share Analysis, 2021 & 2030
  • 7.2. County Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2021
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. U.K.
      • 7.8.2.1. U.K. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. France
      • 7.8.4.1. France market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Japan market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.3. China
      • 7.9.3.1. China market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.9.4. India
      • 7.9.4.1. India market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.10. Latin America
    • 7.10.1. market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.11. Middle East & Africa
    • 7.11.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2021
    • 8.3.4. Stryker Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Procedure benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Procedure benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. AbbVie Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Procedure benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Zimmer Biomet
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Procedure benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Novartis
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Procedure benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. 21 st Century Medicine
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Procedure benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biolife Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Procedure benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Teva Pharmaceutical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Procedure benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Veloxis Pharmaceuticals
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Procedure benchmarking
      • 8.3.12.4. Strategic initiatives